Renault to continue investing in Romania, says Dacia CEO

Newsroom 05/06/2015 | 15:27

Dacia CEO Nicolas Maure said on Thursday that Renault group will not leave Mioveni, although there is not yet a highway linking Constanta harbor to the West of the country, and will continue investments.

“Renault will not leave Mioveni, even if the highway is not being made yet. In case the Pitesti-Nadlac highway is ready, the road transport time would decrease by five hours, to which we add other five hours reduced for the distance between Pitesti and Constanta. In total we would earn ten hours of transport,” said Maure, at the celebration of ten years of activity of Mioveni’s Alliance International Logistic Network.

He said that Dacia can wait a few years until the Pitesti-Sibiu motorway will be ready.

“Dacia can wait a few years until the highway will be constructed, and afterwards we’ll save up ten hours of transport. Probably the highway works will begin in 2017 and by 2020 will be ready. There might be delays of one-two years until the completion of works, but we will not go,” added Maure, as quoted by Mediafax.

Deputy Mircea Draghici, who is also adviser to prime minister Victor Ponta, said that in June Romania’s National Company of Motorways and National Roads will sign the contract for the feasibility study’s revision.

Staff

BR Magazine | Latest Issue

Download PDF or read online: July 2023 Issue | Business Review Magazine

The July 2023 issue of Business Review Magazine is now available in digital format, featuring the main cover story titled “At a Crossroads: Budget Deficit Endangering Romania’s Economic
Newsroom | 31/07/2023 | 14:14

    You will receive a download link for the latest issue of Business Review Magazine in PDF format, based on the completion of the form below.

    I agree with the Privacy policy of business-review.eu

    I agree with the storage and handling of my data by business-review.eu

    Advertisement Advertisement
    Close ×

    We use cookies for keeping our website reliable and secure, personalising content and ads, providing social media features and to analyse how our website is used.

    Accept & continue